Suven Pharmaceuticals Ltd - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

We are pleased to inform you that the United States Food & Drug Administration (US FDA) has completed the surveillance unspection of Casper Pharma Private Limited in Hyderabad (WOS of our Company) The Inspection took place frol July 8, 2024 to July 12, 2024. Following the inspection, we have been issed a Form 483 with two observations, which are procedural in nature.